191 related articles for article (PubMed ID: 37935837)
1. New insights into the role of the immune inhibitory receptor VSTM1 in autoimmune disease.
Miao N; Wang J
Cell Mol Immunol; 2024 Jan; 21(1):95-96. PubMed ID: 37935837
[No Abstract] [Full Text] [Related]
2. Oxidized galectin-1 in SLE fails to bind the inhibitory receptor VSTM1 and increases reactive oxygen species levels in neutrophils.
Jiang X; Xiao X; Li H; Gong Y; Wang M; Yang H; Zhao L; Jiang Y; Wei Y; Zhao C; Li J; Chen Y; Feng S; Deng H; Ma S; Xu Y; Liu Y; Tsokos GC; Jiang M; Zhang X
Cell Mol Immunol; 2023 Nov; 20(11):1339-1351. PubMed ID: 37737309
[TBL] [Abstract][Full Text] [Related]
3. VSTM1-v2 does not drive human Th17 cell differentiation: A replication study.
von Richthofen HJ; Hafkamp FMJ; van Haperen A; de Jong EC; Meyaard L
PLoS One; 2023; 18(4):e0284404. PubMed ID: 37053248
[TBL] [Abstract][Full Text] [Related]
4. Identification of rat Vstm1 with conservative anti-inflammatory effect between rat and human homologs.
Hu Y; Sun Y; Li T; Han W; Wang P
Genomics; 2024 Jan; 116(1):110774. PubMed ID: 38163574
[TBL] [Abstract][Full Text] [Related]
5. V‑set and transmembrane domain‑containing 1 is silenced in human hematopoietic malignancy cell lines with promoter methylation and has inhibitory effects on cell growth.
Li T; Guo X; Wang W; Mo X; Wang P; Han W
Mol Med Rep; 2015 Feb; 11(2):1344-51. PubMed ID: 25351446
[TBL] [Abstract][Full Text] [Related]
6. A functional SNP associated with atopic dermatitis controls cell type-specific methylation of the VSTM1 gene locus.
Kumar D; Puan KJ; Andiappan AK; Lee B; Westerlaken GH; Haase D; Melchiotti R; Li Z; Yusof N; Lum J; Koh G; Foo S; Yeong J; Alves AC; Pekkanen J; Sun LD; Irwanto A; Fairfax BP; Naranbhai V; Common JE; Tang M; Chuang CK; Jarvelin MR; Knight JC; Zhang X; Chew FT; Prabhakar S; Jianjun L; Wang Y; Zolezzi F; Poidinger M; Lane EB; Meyaard L; Rötzschke O
Genome Med; 2017 Feb; 9(1):18. PubMed ID: 28219444
[TBL] [Abstract][Full Text] [Related]
7. Expression of VSTM1-v2 Is Increased in Peripheral Blood Mononuclear Cells from Patients with Rheumatoid Arthritis and Is Correlated with Disease Activity.
Wang D; Li Y; Liu Y; He Y; Shi G
PLoS One; 2016; 11(1):e0146805. PubMed ID: 26760041
[TBL] [Abstract][Full Text] [Related]
8. Enhanced production of secretory glycoprotein VSTM1-v2 with mouse IgGκ signal peptide in optimized HEK293F transient transfection.
Liu H; Zou X; Li T; Wang X; Yuan W; Chen Y; Han W
J Biosci Bioeng; 2016 Feb; 121(2):133-9. PubMed ID: 26140918
[TBL] [Abstract][Full Text] [Related]
9. Predictive and prognostic value of v-set and transmembrane domain-containing 1 expression in monocytes for coronary artery disease.
Wang XF; Xu MC; Mao CY; En-Zhou ; He Q; Qu XQ; Fan YQ; Wang CQ; Zhang JF
Rev Cardiovasc Med; 2021 Sep; 22(3):1009-1017. PubMed ID: 34565102
[TBL] [Abstract][Full Text] [Related]
10. Do inhibitory immune receptors play a role in the etiology of autoimmune disease?
Olde Nordkamp MJ; Koeleman BP; Meyaard L
Clin Immunol; 2014 Jan; 150(1):31-42. PubMed ID: 24333531
[TBL] [Abstract][Full Text] [Related]
11. [Preparation and identification of the polyclonal antibody against human VSTM1].
Li T; Guo XH; Wang PZ; Song QS; Ma DL; Han WL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Dec; 28(12):1291-4. PubMed ID: 23232521
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antitumor activity of triple-regulated oncolytic adenovirus with VSTM1 and daunorubicin in leukemic cells.
Zhou J; Yao QM; Li JL; Chang Y; Li T; Han WL; Wu HP; Li LF; Qian QJ; Ruan GR
Apoptosis; 2016 Oct; 21(10):1179-90. PubMed ID: 27472927
[TBL] [Abstract][Full Text] [Related]
13. VSTM1 regulates monocyte/macrophage function via the NF-κB signaling pathway.
Wang XF; En-Zhou ; Li DJ; Mao CY; He Q; Zhang JF; Fan YQ; Wang CQ
Open Med (Wars); 2021; 16(1):1513-1524. PubMed ID: 34712823
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of monoclonal antibodies against VSTM1.
Li T; Wang W; Chen Y; Han W
Monoclon Antib Immunodiagn Immunother; 2013 Aug; 32(4):283-9. PubMed ID: 23909423
[TBL] [Abstract][Full Text] [Related]
15. T cell receptor revision and immune repertoire changes in autoimmune diseases.
Song R; Jia X; Zhao J; Du P; Zhang JA
Int Rev Immunol; 2022; 41(5):517-533. PubMed ID: 34243694
[TBL] [Abstract][Full Text] [Related]
16. Insights into IL-37, the role in autoimmune diseases.
Xu WD; Zhao Y; Liu Y
Autoimmun Rev; 2015 Dec; 14(12):1170-5. PubMed ID: 26264940
[TBL] [Abstract][Full Text] [Related]
17. Immune checkpoint molecules. Possible future therapeutic implications in autoimmune diseases.
Huang C; Zhu HX; Yao Y; Bian ZH; Zheng YJ; Li L; Moutsopoulos HM; Gershwin ME; Lian ZX
J Autoimmun; 2019 Nov; 104():102333. PubMed ID: 31564474
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor and its role in autoimmune diseases.
Denkinger CM; Metz C; Fingerle-Rowson G; Denkinger MD; Forsthuber T
Arch Immunol Ther Exp (Warsz); 2004; 52(6):389-400. PubMed ID: 15577740
[TBL] [Abstract][Full Text] [Related]
19. Immune deficiency disorders with autoimmunity and abnormalities in immune regulation-monogenic autoimmune diseases.
Lehman HK; Ballow M
Clin Rev Allergy Immunol; 2008 Apr; 34(2):141-5. PubMed ID: 18330725
[TBL] [Abstract][Full Text] [Related]
20. Getting Under the Skin: Targeting Cutaneous Autoimmune Disease.
Vesely MD
Yale J Biol Med; 2020 Mar; 93(1):197-206. PubMed ID: 32226348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
